169 related articles for article (PubMed ID: 17300973)
1. Implantable insulin pumps. A position statement about their clinical use.
Renard E; Schaepelynck-Bélicar P;
Diabetes Metab; 2007 Apr; 33(2):158-66. PubMed ID: 17300973
[TBL] [Abstract][Full Text] [Related]
2. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
3. Implantable insulin pumps: a major piece of computerized diabetes therapy.
Selam JL
Horm Metab Res Suppl; 1990; 24():144-54. PubMed ID: 2272620
[TBL] [Abstract][Full Text] [Related]
4. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
[TBL] [Abstract][Full Text] [Related]
5. [The implantable insulin pump in the treatment of diabetes. Hopes and reality?].
Vague P; Lassmann-Vague V; Belicar P; Alessis C
Bull Acad Natl Med; 1996 Apr; 180(4):831-41; discussion 841-3. PubMed ID: 8925331
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience in human diabetics with portable and implantable insulin minipumps.
Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ
Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370
[TBL] [Abstract][Full Text] [Related]
7. Controlled drug delivery in the treatment of diabetes mellitus.
Irsigler K; Kritz H; Lovett RG
Crit Rev Ther Drug Carrier Syst; 1985; 1(3):189-280. PubMed ID: 3912064
[TBL] [Abstract][Full Text] [Related]
8. Insulin pumps and glucose regulation.
Thompson JS; Duckworth WC
World J Surg; 2001 Apr; 25(4):523-6. PubMed ID: 11344407
[TBL] [Abstract][Full Text] [Related]
9. Current status and future of implantable insulin pumps for the treatment of diabetes.
Catargi B
Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
[TBL] [Abstract][Full Text] [Related]
10. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
11. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
12. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents.
Kapellen TM; Heidtmann B; Bachmann J; Ziegler R; Grabert M; Holl RW
Diabet Med; 2007 Aug; 24(8):836-42. PubMed ID: 17650157
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
Dornhorst A; Lüddeke HJ; Sreenan S; Koenen C; Hansen JB; Tsur A; Landstedt-Hallin L
Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
Bruttomesso D; Costa S; Baritussio A
Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
[TBL] [Abstract][Full Text] [Related]
15. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
[TBL] [Abstract][Full Text] [Related]
16. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
Hermansen K; Dornhorst A; Sreenan S
Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
[TBL] [Abstract][Full Text] [Related]
17. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
18. External and implantable insulin pumps: current place in the treatment of diabetes.
Selam JL
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S333-40. PubMed ID: 11460581
[TBL] [Abstract][Full Text] [Related]
19. [From external to implantable insulin pump, can we close the loop?].
Renard E; Costalat G; Bringer J
Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetes mellitus using an external insulin pump in clinical practice.
Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B
Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
